Jiexue Zhong1, Yuhong Duan2
1Shaanxi University of Chinese Medicine, Xianyang, 712046, Shaanxi, China
2Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shaanxi, China
Glycolipid metabolism disease (GLMD) is a group of diseases that appear single or combined with hyperglycemia, dyslipidemia, non-alcoholic fatty liver disease, overweight, hypertension, atherosclerosis, etc., and need to be prevented and controlled as a whole. At present, the research and development and application of western medicine are still mostly studied for a single disease, the comprehensive compliance rate is low, and traditional Chinese medicine has unique advantages in the treatment of GLMD.
Traditional Chinese medicine treatment; Glycolipid metabolic disease; research progress
Jiexue Zhong, Yuhong Duan. Research progress on the effect of traditional Chinese medicine on glycolipid metabolism diseases. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 5: 72-78. https://doi.org/10.25236/IJFM.2023.050513.
 World Federation of Chinese Medicine Societies. International Clinical Practice Guideline of Chinese Medicine Glucolipid Metabolic Disorders(2021-10-14) [J]. World Chinese Medicine, 2021, 16(22):3278-3284.
 Diabetes Branch of Chinese Medical Association. Chinese guidelines for the prevention and treatment of type 2 diabetes mellitus (2020 edition) [J]. Chinese Journal of Diabetes, 2021, 13(04): 315-409.
 Chinese Joint Committee on the Revision of Guidelines for the Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines for the prevention and treatment of dyslipidemia in adults (2016 revised edition) [J]. Chinese Journal of Cardiology, 2016, 44(10):833-853.
 Fan N, Peng L, Xia Z, et al. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study [J]. Lipids Health Dis. 2019; 18(1):39.
 Zhao Xinxiang. Diabetes mellitus in old age should be treated from the kidneys [J]. Journal of Modern Integrative Medicine, 2003, 12(3):3.
 Qian Yuliang. Kidney and Spleen Blood Decoction for the treatment of type 2 diabetes mellitus in 72 clinical double examinations [J]. Hunan Journal of Traditional Chinese Medicine, 1999, 15(1):7-8.
 Lu Yajuan. Auto-leveling liver lipid-lowering pills for hyperlipidemia in 45 cases [J]. Liaoning Journal of Traditional Chinese Medicine, 2000(04):192.
 Gong Zhenling, Jin Guochun, Kang Shengqun. Pancreatic health capsules in the treatment of type 2 diabetes, 125 cases of clinical study [J]. Hebei Traditional Chinese Medicine, 2002; 24(2):83-86.
 Shi Xizhi, Wang Jifeng. Clinical analysis of 92 cases of diabetic hyperlipidemia by removing stasis and lowering lipids [J]. Jilin Traditional Chinese Medicine Medicine.2000, 20(4):28.
 Liu Yinghua, Teng Junying, Zheng Zixin, et al. Effects of mulberry leaf extract on postprandial blood glucose and α-glucosidase activity [J]. Chinese Clinical Rehabilitation, 2004, 8(27):5896-5897.
 He Shengwen, Zhao Renhong, Chen Jingwu, et al. Discussion on the mechanism of aortic foam cell formation in purslane against rabbits [J]. Chinese Journal of Public Health, 2004, 20(1):35-36.
 Nian Hong, Song Baohui, Wang Guan. Effects of Ginkgo biloba extract on oxidative stress in experimental diabetic rats [J]. Journal of Mudanjiang Medical College, 2004, 25(4):3-6.